Image

Global Pigmentation Disorders Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Pigmentation Disorders Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Jul 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Pigmentation Disorders Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 560.93 USD Million
Diagram Market Size (Forecast Year) USD 630.35 USD Million
Diagram CAGR %

Major Markets Players

  • Zerigo Health
  • Bausch Health Companies
  • Glenmark Pharmaceuticals
  • Novartis
  • Pfizer

Global Pigmentation Disorders Treatment Market, By Disease Type (Melasma, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation, and Others), Treatment Type (Pharmacological Treatment, Non-invasive Treatment, and Surgery), Drugs (Calcineurin Inhibitors, Melanocyte-Stimulating Hormone, and Other),  Route of Administration (Oral, Topical, and Others), End-Users (Dermatology Clinics, Aesthetic Clinics, Homecare, Hospitals, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Industry Trends and Forecast to 2030.

Pigmentation Disorders Treatment Market

Pigmentation Disorders Treatment Market Analysis and Size:

The increasing prevalence of pigmentation disorders across the globe is one of the major factors driving the growth of the treatment market for pigmentation disorders. The growing awareness and patient education, increasing disposable income, and healthcare expenditure accelerates the pigmentation disorders treatment market growth.

Data Bridge Market Research analyses that the global pigmentation disorders treatment market, which was USD 6,560.60 million in 2022, would rocket up to USD 12,369.18 million by 2030 and is expected to undergo a CAGR of 7.30 % during the forecast period. The melasma segment dominates the disease type segment of the pigmentation disorders treatment market owing to the advancements in technology that have led to the development of advancements in drugs for various use. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Pigmentation Disorders Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Disease Type (Melasma, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation, and Others), Treatment Type (Pharmacological Treatment, Non-invasive Treatment, and Surgery), Drugs (Calcineurin Inhibitors, Melanocyte-Stimulating Hormone, and Other),  Route of Administration (Oral, Topical, and Others), End-Users (Dermatology Clinics, Aesthetic Clinics, Homecare, Hospitals, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)

Countries Covered

U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, rest of Middle East and Africa

Market Players Covered

Zerigo Health.(U.S.), Bausch Health Companies Inc. (U.S.),, Glenmark Pharmaceuticals Limited (India), Novartis AG (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Mylan N.V. (U.S.), Bayer AG (U.S.), CLINUVEL PHARMACEUTICALS LTD (Australia), Incyte (U.S.), Strides Pharma Science Limited (India), Panacea Biotec Ltd (U.S.), Belcher Pharmaceuticals, LLC (U.S.), LEO Pharma A/S (Germany), Astellas Pharma Inc. (U.S.), Episciences(U.S.), and Obagi Cosmeceuticals LLC (U.S.)

Market Opportunities

  • Rising Disposable Income and Affordability
  • Growing Geriatric Population

Market Definition

The global pigmentation disorders treatment market refers to the market for various products and therapies used to treat pigmentation disorders, which are conditions that affect the color of the skin, hair, or eyes. Pigmentation disorders can manifest as hypo-pigmentation (loss of skin color) or hyper-pigmentation (excessive skin color).

These disorders can be caused by various factors such as genetic mutations, hormonal changes, exposure to sunlight, skin injuries, or certain medical conditions. Some common pigmentation disorders include vitiligo, melasma, albinism, and post-inflammatory hyperpigmentation.

Global Pigmentation Disorders Treatment Market Dynamics

Drivers

  • Increasing Prevalence of Pigmentation Disorders:

The rising prevalence of pigmentation disorders, such as melasma, vitiligo, and post-inflammatory hyperpigmentation, is a significant driver for the market. Factors such as sun exposure, hormonal changes, and genetic predisposition contribute to the growing incidence of these disorders, creating a demand for effective treatment options.

  • Technological Advancements:

Advancements in treatment modalities, such as laser therapies, chemical peels, and cryosurgery, have significantly improved the outcomes of pigmentation disorders treatment. These technological advancements have led to the development of more precise, efficient, and less invasive procedures, driving market growth.

  • Increasing Awareness and Cosmetic Concerns:

Growing awareness about the availability of various treatment options for pigmentation disorders has contributed to an increased demand for these treatments. Additionally, the rising emphasis on physical appearance and aesthetic concerns among the population has led to a surge in demand for pigmentation correction procedures, further driving the market growth.

Opportunities

  • Rising Disposable Income and Affordability:

Increasing disposable income and affordability among individuals in developing economies have made pigmentation disorder treatments more accessible. As a result, a larger proportion of the population can afford these treatments, expanding the market.

  • Growing Geriatric Population:

The global geriatric population is rising, and pigmentation disorders are more prevalent among older individuals. Age-related pigmentation disorders, such as senile and solar lentigines, are becoming increasingly common. This demographic trend contributes to the market's growth as the demand for effective treatment options for pigmentation disorders increases.

Challenges/ Restraints

  • High Treatment Costs:

The cost of pigmentation disorders treatment can be high, especially for advanced therapies such as laser treatments or cosmetic procedures. Affordability issues can limit access to these treatments, particularly in developing countries with limited healthcare resources.

  • Side Effects and Risks:

Some pigmentation disorders treatment options, such as chemical peels or laser therapy, may carry potential risks and side effects. Concerns about adverse reactions or complications may deter individuals from seeking or continuing treatment.

This global pigmentation disorders treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Global Pigmentation Disorders Treatment Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In June 2023, Merck, known as MSD outside of the United States and Canada, announced the completion of the acquisition of the Prometheus Biosciences, Inc. (“Prometheus”). Prometheus is now a wholly-owned subsidiary of Merck, and the common stock of Prometheus will no longer be listed or traded on the Nasdaq global market
  • In May 2023, Sandoz, a global leader in off-patent (generic and biosimilar) medicines, announced a multi-year partnership with Just - Evotec Biologics, the Seattle-based subsidiary of Evotec SE.

Global Pigmentation Disorders Treatment Market scope

The global pigmentation disorders treatment market is segmented on the basis of disease type, treatment type, drugs, route of administration, end users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

By disease type

  • Melasma
  • Vitiligo
  • Albinism
  • Post-Inflammatory Hyperpigmentation
  • Others

By treatment type

  • Pharmacological Treatment
  • Non-invasive Treatment
  • Surgery

By drugs

  • Calcineurin Inhibitors
  • Melanocyte-Stimulating Hormone
  • Other

By Route of administration

  • Oral
  • Topical
  • Others

By end users

  • Dermatology Clinics
  • Aesthetic Clinics
  • Homecare
  • Hospitals
  • Others

By Distribution channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Global Pigmentation Disorders Treatment Market regional analysis/insights

The global pigmentation disorders treatment market is analysed and market size insights and trends are provided for country, disease type, treatment type, drugs, route of administration, end users and distribution channel as referenced above.

The countries covered in the global pigmentation disorders treatment market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, rest of Middle East and Africa.

North America dominates the pigmentation disorders treatment market due to major key players, high disposable income, high healthcare expenditure, and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global pigmentation disorders treatment market    also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Global Pigmentation Disorders Treatment Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Global Pigmentation Disorders Treatment Market. The data is available for historic period 2010-2020.

Competitive Landscape and Global Pigmentation Disorders Treatment Market share Analysis

The global pigmentation disorders treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Global Pigmentation Disorders Treatment Market.

Some of the major players operating in the market are:

  • Zerigo Health.(U.S.)
  • Bausch Health Companies Inc. (U.S.)
  •  Glenmark Pharmaceuticals Limited (India)
  • Novartis AG (U.S.)
  • Pfizer Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (U.S.)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Mylan N.V. (U.S.)
  • Bayer AG (U.S.)
  • CLINUVEL PHARMACEUTICALS LTD (Australia)
  • Incyte (U.S.)
  • Strides Pharma Science Limited (India)
  • Panacea Biotec Ltd (U.S.)
  • Belcher Pharmaceuticals, LLC (U.S.)
  • LEO Pharma A/S (Germany)
  • Astellas Pharma Inc. (U.S.)
  • Episciences(U.S.)
  • Obagi Cosmeceuticals LLC (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Pigmentation Disorders Treatment Market will be worth USD 12,369.18 million by 2030.
The Pigmentation Disorders Treatment Market Growth Rate is 7.30% during the forecast period.
The Increasing Awareness and Cosmetic Concerns, Technological Advancements, and Increasing Prevalence of Pigmentation Disorders are the Growth Drivers of the Pigmentation Disorders Treatment Market.
The disease type, treatment type, drugs, route of administration, end users, and distribution channel are the factors on which the Pigmentation Disorders Treatment Market research is based.
Merck, known as MSD outside of the United States and Canada, announced the completion of the acquisition of Prometheus Biosciences, and Sandoz, a global leader in off-patent (generic and biosimilar) medicines, announced a multi-year partnership with Just - Evotec Biologics, the Seattle-based subsidiary of Evotec SE are the latest developments in the Pigmentation Disorders Treatment Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials